Which antibiotic classes are most associated with QT prolongation and what monitoring should be performed?

• A. Macrolides and fluoroquinolones; monitor ECG QTc, electrolytes (K, Mg), and avoid when risk factors present
• B. Penicillins and cephalosporins; monitor liver enzymes
• C. Tetracyclines and aminoglycosides; monitor hearing
• D. Carbapenems; monitor blood glucose

Answer: (A)

QT prolongation with antibiotics occurs when certain drugs interfere with cardiac repolarization, typically by blocking the hERG potassium channels that help terminate the ventricular action potential. This makesmacrolides and fluoroquinolones the class most consistently linked to this effect. The result is a longer QT interval on the ECG and a higher risk of torsades de pointes, especially if other risk factors are present such as electrolyte abnormalities (low potassium or magnesium), bradycardia, or concomitant use of other QT-prolonging medications.

Therefore, monitoring should focus on the QTc interval and correcting electrolytes. Before or early in therapy, obtain a baseline ECG and check potassium and magnesium levels, then monitor QTc during treatment and recheck electrolytes if potassium or magnesium are low or if the patient develops symptoms like palpitations or syncope. Avoid using these antibiotics in patients with known long QT, a history of torsades, significant electrolyte disturbances, or those taking other QT-prolonging drugs, and consider alternative agents if risk factors are present.

The other antibiotic classes listed do not have as strong an association with QT prolongation, so their common monitoring priorities differ (for example, liver enzyme monitoring for some agents, or hearing risk with aminoglycosides).